Share Price and Basic Stock Data
Last Updated: December 9, 2025, 9:50 pm
| PEG Ratio | 3.86 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Veedol Corporation Ltd operates within the lubricants industry, a sector characterized by its steady demand and growth potential. The company’s reported revenue for FY 2025 stood at ₹1,970 Cr, reflecting a modest increase from ₹1,933 Cr in FY 2024. This trajectory indicates a resilient performance amid fluctuating market conditions. Notably, the quarterly sales figures showed consistency, with the most recent quarters revealing sales of ₹496 Cr in December 2023 and ₹487 Cr in March 2024. Such stability suggests that the company has maintained its market position effectively, even as it navigates the challenges posed by rising raw material costs and competitive pressures. With a market capitalization of ₹2,820 Cr and a current price of ₹1,619, Veedol appears to be well-regarded among investors, particularly given its P/E ratio of 14.5, which seems attractive relative to industry peers.
Profitability and Efficiency Metrics
Veedol’s profitability metrics present a solid picture, with a return on equity (ROE) reported at 19.8% and return on capital employed (ROCE) at 23.7%. These figures are commendable, particularly in a sector where efficient capital utilization is critical. The company’s operating profit margin (OPM) stood at 10% for FY 2025, which, while lower than previous years, remains competitive. The operating profit for the same period recorded ₹194 Cr, which indicates that the company is managing its costs effectively despite the rising expense base, which reached ₹1,776 Cr. Furthermore, the interest coverage ratio of 59.94x underscores the company’s ability to meet its interest obligations comfortably, reflecting a low debt level of just ₹22 Cr. This financial prudence allows Veedol to maintain a healthy operational framework, but the declining OPM trend warrants attention as it could indicate potential pressure on margins if raw material costs continue to increase.
Balance Sheet Strength and Financial Ratios
The balance sheet of Veedol Corporation Ltd appears robust, with total reserves rising to ₹911 Cr, a significant increase from ₹824 Cr the previous year. This growth in reserves is indicative of the company’s ability to retain earnings and reinvest in its operations, which is vital for long-term sustainability. The company’s total borrowings are minimal at ₹22 Cr, resulting in a debt-to-equity ratio that remains virtually negligible. This translates to a solid financial foundation, allowing for strategic investments without the burden of high interest obligations. However, the cash conversion cycle (CCC) of 106 days does raise some concerns, suggesting that the company may be tying up capital in inventory and receivables longer than optimal. While the current ratio of 3.01x illustrates a comfortable liquidity position, it is essential for the company to manage its working capital more efficiently to enhance cash flow and operational agility.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Veedol indicates a strong promoter presence, with promoters holding 64.58% of the company as of March 2025. This level of insider ownership typically reflects confidence in the company’s future and aligns the interests of management with those of minority shareholders. Foreign institutional investors (FIIs) hold a modest 1.37%, while domestic institutional investors (DIIs) account for 1.17%, suggesting a limited but stable interest from larger institutional players. The public stake has fluctuated around 30.41%, indicating a reasonable level of retail investor participation. Overall, the distribution of shares suggests a healthy balance of control and public ownership, fostering an environment of trust and confidence among investors. However, the relatively low institutional ownership could imply that the stock is yet to gain traction among larger investment entities, which may limit liquidity.
Outlook, Risks, and Final Insight
Looking ahead, Veedol Corporation Ltd is poised for moderate growth, supported by its solid financial metrics and strategic management. However, several risks loom on the horizon. The lubricants market is susceptible to fluctuations in crude oil prices, which can significantly impact raw material costs and, consequently, profit margins. Additionally, the company’s ability to manage its inventory effectively will be critical in optimizing its cash conversion cycle. On the other hand, the strong promoter backing and healthy financial ratios provide a cushion against market volatility. Investors should remain vigilant about the company’s margin trends and cost management strategies while considering the inherent risks in the sector. Overall, with a stable operating history and potential for strategic growth, Veedol presents as a compelling option for those seeking exposure to the lubricants market, provided they are aware of the external pressures that could influence performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Veedol Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gandhar Oil Refinery (India) Ltd | 1,194 Cr. | 122 | 245/121 | 12.8 | 132 | 0.41 % | 10.6 % | 6.65 % | 2.00 |
| Continental Petroleums Ltd | 89.2 Cr. | 105 | 137/99.0 | 25.9 | 79.7 | 0.00 % | 21.3 % | 16.4 % | 5.00 |
| Veedol Corporation Ltd | 2,775 Cr. | 1,599 | 2,035/1,275 | 14.3 | 561 | 3.38 % | 23.7 % | 19.8 % | 2.00 |
| Savita Oil Technologies Ltd | 2,524 Cr. | 368 | 602/295 | 16.6 | 255 | 1.09 % | 9.84 % | 6.10 % | 2.00 |
| Gulf Oil Lubricants India Ltd | 5,624 Cr. | 1,139 | 1,332/911 | 15.1 | 335 | 4.21 % | 28.3 % | 25.5 % | 2.00 |
| Industry Average | 5,161.67 Cr | 508.23 | 15.78 | 206.84 | 1.94% | 22.82% | 17.80% | 3.29 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 439 | 448 | 497 | 470 | 474 | 474 | 496 | 487 | 479 | 476 | 483 | 532 | 514 |
| Expenses | 399 | 420 | 463 | 429 | 435 | 433 | 455 | 439 | 437 | 430 | 444 | 464 | 455 |
| Operating Profit | 40 | 28 | 34 | 41 | 39 | 42 | 42 | 48 | 41 | 46 | 38 | 68 | 59 |
| OPM % | 9% | 6% | 7% | 9% | 8% | 9% | 8% | 10% | 9% | 10% | 8% | 13% | 11% |
| Other Income | 6 | 4 | 6 | 6 | 8 | 8 | 8 | 12 | 14 | 9 | 6 | 10 | 13 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 8 | 7 | 8 | 8 |
| Profit before tax | 42 | 28 | 35 | 43 | 42 | 45 | 45 | 55 | 50 | 46 | 37 | 69 | 64 |
| Tax % | 19% | 26% | 26% | 19% | 26% | 22% | 25% | 23% | 26% | 25% | -1% | 13% | 22% |
| Net Profit | 34 | 20 | 26 | 34 | 31 | 35 | 34 | 43 | 37 | 35 | 37 | 60 | 50 |
| EPS in Rs | 19.35 | 11.73 | 14.89 | 19.75 | 17.90 | 20.21 | 19.27 | 24.63 | 21.30 | 19.86 | 21.43 | 34.26 | 28.51 |
Last Updated: August 20, 2025, 2:15 am
Below is a detailed analysis of the quarterly data for Veedol Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 514.00 Cr.. The value appears to be declining and may need further review. It has decreased from 532.00 Cr. (Mar 2025) to 514.00 Cr., marking a decrease of 18.00 Cr..
- For Expenses, as of Jun 2025, the value is 455.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 464.00 Cr. (Mar 2025) to 455.00 Cr., marking a decrease of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Mar 2025) to 11.00%, marking a decrease of 2.00%.
- For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2025) to 64.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 13.00% (Mar 2025) to 22.00%, marking an increase of 9.00%.
- For Net Profit, as of Jun 2025, the value is 50.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 10.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 28.51. The value appears to be declining and may need further review. It has decreased from 34.26 (Mar 2025) to 28.51, marking a decrease of 5.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 12, 2025, 1:49 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 973 | 1,037 | 974 | 1,130 | 1,275 | 1,377 | 1,317 | 1,258 | 1,536 | 1,854 | 1,933 | 1,970 |
| Expenses | 880 | 956 | 860 | 994 | 1,136 | 1,246 | 1,178 | 1,094 | 1,388 | 1,712 | 1,760 | 1,776 |
| Operating Profit | 93 | 81 | 113 | 136 | 139 | 131 | 138 | 164 | 147 | 142 | 173 | 194 |
| OPM % | 10% | 8% | 12% | 12% | 11% | 9% | 10% | 13% | 10% | 8% | 9% | 10% |
| Other Income | 17 | 163 | 24 | 35 | 32 | 32 | 38 | 38 | 30 | 22 | 31 | 39 |
| Interest | 0 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 4 |
| Depreciation | 9 | 11 | 7 | 9 | 9 | 10 | 12 | 14 | 15 | 15 | 15 | 29 |
| Profit before tax | 100 | 232 | 129 | 159 | 159 | 149 | 161 | 185 | 160 | 147 | 187 | 202 |
| Tax % | 35% | 32% | 39% | 32% | 33% | 35% | 24% | 24% | 23% | 22% | 24% | 16% |
| Net Profit | 65 | 159 | 86 | 108 | 107 | 97 | 122 | 141 | 123 | 115 | 143 | 169 |
| EPS in Rs | 37.67 | 92.18 | 49.39 | 61.87 | 61.05 | 55.41 | 69.75 | 80.76 | 70.54 | 65.76 | 82.03 | 96.85 |
| Dividend Payout % | 27% | 19% | 50% | 47% | 56% | 82% | 70% | 72% | 76% | 62% | 62% | 54% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 144.62% | -45.91% | 25.58% | -0.93% | -9.35% | 25.77% | 15.57% | -12.77% | -6.50% | 24.35% | 18.18% |
| Change in YoY Net Profit Growth (%) | 0.00% | -190.53% | 71.49% | -26.51% | -8.42% | 35.12% | -10.20% | -28.34% | 6.26% | 30.85% | -6.17% |
Veedol Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 7% |
| 3 Years: | 12% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 13% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 20% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 10, 2025, 3:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.85 | 0.85 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 381 | 499 | 585 | 611 | 649 | 638 | 679 | 735 | 716 | 761 | 824 | 911 | 974 |
| Borrowings | 9 | 21 | 28 | 29 | 42 | 39 | 38 | 18 | 14 | 5 | 1 | 22 | 21 |
| Other Liabilities | 213 | 217 | 231 | 255 | 256 | 249 | 248 | 286 | 302 | 330 | 320 | 317 | 331 |
| Total Liabilities | 604 | 738 | 846 | 897 | 949 | 928 | 967 | 1,040 | 1,036 | 1,099 | 1,149 | 1,253 | 1,329 |
| Fixed Assets | 122 | 194 | 148 | 231 | 242 | 249 | 263 | 277 | 270 | 272 | 294 | 340 | 346 |
| CWIP | 1 | -0 | 2 | 0 | 3 | 2 | 12 | 4 | 3 | 2 | 10 | 7 | 16 |
| Investments | 0 | 0 | 68 | 65 | 70 | 69 | 76 | 74 | 70 | 70 | 73 | 78 | 80 |
| Other Assets | 481 | 544 | 628 | 600 | 634 | 608 | 616 | 686 | 692 | 756 | 771 | 827 | 887 |
| Total Assets | 604 | 738 | 846 | 897 | 949 | 928 | 967 | 1,040 | 1,036 | 1,099 | 1,149 | 1,253 | 1,329 |
Below is a detailed analysis of the balance sheet data for Veedol Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Reserves, as of Sep 2025, the value is 974.00 Cr.. The value appears strong and on an upward trend. It has increased from 911.00 Cr. (Mar 2025) to 974.00 Cr., marking an increase of 63.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 22.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 331.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 317.00 Cr. (Mar 2025) to 331.00 Cr., marking an increase of 14.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,329.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,253.00 Cr. (Mar 2025) to 1,329.00 Cr., marking an increase of 76.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 346.00 Cr.. The value appears strong and on an upward trend. It has increased from 340.00 Cr. (Mar 2025) to 346.00 Cr., marking an increase of 6.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2025) to 80.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 887.00 Cr.. The value appears strong and on an upward trend. It has increased from 827.00 Cr. (Mar 2025) to 887.00 Cr., marking an increase of 60.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,329.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,253.00 Cr. (Mar 2025) to 1,329.00 Cr., marking an increase of 76.00 Cr..
Notably, the Reserves (974.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 84.00 | 60.00 | 85.00 | 107.00 | 97.00 | 92.00 | 100.00 | 146.00 | 133.00 | 137.00 | 172.00 | 172.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 63 | 62 | 65 | 54 | 52 | 42 | 47 | 50 | 47 | 42 | 54 |
| Inventory Days | 112 | 84 | 105 | 115 | 93 | 85 | 102 | 150 | 109 | 90 | 84 | 104 |
| Days Payable | 73 | 60 | 89 | 96 | 90 | 80 | 87 | 107 | 79 | 64 | 47 | 52 |
| Cash Conversion Cycle | 105 | 87 | 78 | 84 | 57 | 56 | 56 | 90 | 80 | 73 | 79 | 106 |
| Working Capital Days | 83 | 62 | 41 | 65 | 54 | 53 | 48 | 71 | 66 | 59 | 86 | 92 |
| ROCE % | 28% | 18% | 23% | 26% | 24% | 22% | 23% | 26% | 22% | 20% | 24% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 11,286 | 0.23 | 3.05 | 11,286 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 5.00 |
| Basic EPS (Rs.) | 99.29 | 84.10 | 67.37 | 72.32 | 415.80 |
| Diluted EPS (Rs.) | 99.29 | 84.10 | 67.37 | 72.32 | 415.80 |
| Cash EPS (Rs.) | 99.89 | 85.22 | 72.41 | 75.36 | 411.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 537.68 | 486.76 | 449.18 | 423.43 | 2166.35 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 537.68 | 486.76 | 449.18 | 423.43 | 2166.35 |
| Revenue From Operations / Share (Rs.) | 1159.11 | 1135.99 | 1090.47 | 903.36 | 3701.41 |
| PBDIT / Share (Rs.) | 125.17 | 112.29 | 92.45 | 98.18 | 548.35 |
| PBIT / Share (Rs.) | 108.39 | 103.34 | 83.30 | 89.08 | 506.82 |
| PBT / Share (Rs.) | 102.45 | 102.28 | 82.42 | 88.14 | 499.74 |
| Net Profit / Share (Rs.) | 83.12 | 76.26 | 63.26 | 66.26 | 370.03 |
| NP After MI And SOA / Share (Rs.) | 99.26 | 84.08 | 67.35 | 72.30 | 415.68 |
| PBDIT Margin (%) | 10.79 | 9.88 | 8.47 | 10.86 | 14.81 |
| PBIT Margin (%) | 9.35 | 9.09 | 7.63 | 9.86 | 13.69 |
| PBT Margin (%) | 8.83 | 9.00 | 7.55 | 9.75 | 13.50 |
| Net Profit Margin (%) | 7.17 | 6.71 | 5.80 | 7.33 | 9.99 |
| NP After MI And SOA Margin (%) | 8.56 | 7.40 | 6.17 | 8.00 | 11.23 |
| Return on Networth / Equity (%) | 18.46 | 17.27 | 14.99 | 17.07 | 19.18 |
| Return on Capital Employeed (%) | 18.75 | 19.88 | 17.33 | 19.58 | 21.81 |
| Return On Assets (%) | 13.47 | 12.36 | 10.42 | 11.86 | 13.58 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 1.64 | 1.71 | 1.51 | 1.28 | 1.11 |
| Current Ratio (X) | 3.01 | 2.82 | 2.64 | 2.62 | 2.72 |
| Quick Ratio (X) | 1.78 | 1.80 | 1.56 | 1.52 | 1.58 |
| Inventory Turnover Ratio (X) | 6.44 | 3.71 | 3.43 | 2.69 | 2.33 |
| Dividend Payout Ratio (NP) (%) | 53.68 | 57.29 | 63.91 | 113.40 | 59.18 |
| Dividend Payout Ratio (CP) (%) | 45.92 | 51.77 | 56.27 | 100.72 | 53.80 |
| Earning Retention Ratio (%) | 46.32 | 42.71 | 36.09 | -13.40 | 40.82 |
| Cash Earning Retention Ratio (%) | 54.08 | 48.23 | 43.73 | -0.72 | 46.20 |
| Interest Coverage Ratio (X) | 59.94 | 106.65 | 105.48 | 104.32 | 77.36 |
| Interest Coverage Ratio (Post Tax) (X) | 42.65 | 73.42 | 73.17 | 71.40 | 53.20 |
| Enterprise Value (Cr.) | 2277.15 | 2335.08 | 1260.12 | 1753.04 | 1303.05 |
| EV / Net Operating Revenue (X) | 1.16 | 1.21 | 0.67 | 1.14 | 1.04 |
| EV / EBITDA (X) | 10.70 | 12.23 | 8.02 | 10.50 | 6.99 |
| MarketCap / Net Operating Revenue (X) | 1.18 | 1.23 | 0.76 | 1.23 | 1.17 |
| Retention Ratios (%) | 46.31 | 42.70 | 36.08 | -13.40 | 40.81 |
| Price / BV (X) | 2.54 | 2.87 | 1.86 | 2.62 | 2.00 |
| Price / Net Operating Revenue (X) | 1.18 | 1.23 | 0.76 | 1.23 | 1.17 |
| EarningsYield | 0.07 | 0.06 | 0.08 | 0.06 | 0.09 |
After reviewing the key financial ratios for Veedol Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 99.29. This value is within the healthy range. It has increased from 84.10 (Mar 24) to 99.29, marking an increase of 15.19.
- For Diluted EPS (Rs.), as of Mar 25, the value is 99.29. This value is within the healthy range. It has increased from 84.10 (Mar 24) to 99.29, marking an increase of 15.19.
- For Cash EPS (Rs.), as of Mar 25, the value is 99.89. This value is within the healthy range. It has increased from 85.22 (Mar 24) to 99.89, marking an increase of 14.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 537.68. It has increased from 486.76 (Mar 24) to 537.68, marking an increase of 50.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 537.68. It has increased from 486.76 (Mar 24) to 537.68, marking an increase of 50.92.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,159.11. It has increased from 1,135.99 (Mar 24) to 1,159.11, marking an increase of 23.12.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 125.17. This value is within the healthy range. It has increased from 112.29 (Mar 24) to 125.17, marking an increase of 12.88.
- For PBIT / Share (Rs.), as of Mar 25, the value is 108.39. This value is within the healthy range. It has increased from 103.34 (Mar 24) to 108.39, marking an increase of 5.05.
- For PBT / Share (Rs.), as of Mar 25, the value is 102.45. This value is within the healthy range. It has increased from 102.28 (Mar 24) to 102.45, marking an increase of 0.17.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 83.12. This value is within the healthy range. It has increased from 76.26 (Mar 24) to 83.12, marking an increase of 6.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 99.26. This value is within the healthy range. It has increased from 84.08 (Mar 24) to 99.26, marking an increase of 15.18.
- For PBDIT Margin (%), as of Mar 25, the value is 10.79. This value is within the healthy range. It has increased from 9.88 (Mar 24) to 10.79, marking an increase of 0.91.
- For PBIT Margin (%), as of Mar 25, the value is 9.35. This value is below the healthy minimum of 10. It has increased from 9.09 (Mar 24) to 9.35, marking an increase of 0.26.
- For PBT Margin (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 8.83, marking a decrease of 0.17.
- For Net Profit Margin (%), as of Mar 25, the value is 7.17. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 7.17, marking an increase of 0.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.56. This value is within the healthy range. It has increased from 7.40 (Mar 24) to 8.56, marking an increase of 1.16.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.46. This value is within the healthy range. It has increased from 17.27 (Mar 24) to 18.46, marking an increase of 1.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.75. This value is within the healthy range. It has decreased from 19.88 (Mar 24) to 18.75, marking a decrease of 1.13.
- For Return On Assets (%), as of Mar 25, the value is 13.47. This value is within the healthy range. It has increased from 12.36 (Mar 24) to 13.47, marking an increase of 1.11.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.64. It has decreased from 1.71 (Mar 24) to 1.64, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.82 (Mar 24) to 3.01, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has decreased from 1.80 (Mar 24) to 1.78, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.44. This value is within the healthy range. It has increased from 3.71 (Mar 24) to 6.44, marking an increase of 2.73.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 53.68. This value exceeds the healthy maximum of 50. It has decreased from 57.29 (Mar 24) to 53.68, marking a decrease of 3.61.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 45.92. This value is within the healthy range. It has decreased from 51.77 (Mar 24) to 45.92, marking a decrease of 5.85.
- For Earning Retention Ratio (%), as of Mar 25, the value is 46.32. This value is within the healthy range. It has increased from 42.71 (Mar 24) to 46.32, marking an increase of 3.61.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 54.08. This value is within the healthy range. It has increased from 48.23 (Mar 24) to 54.08, marking an increase of 5.85.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 59.94. This value is within the healthy range. It has decreased from 106.65 (Mar 24) to 59.94, marking a decrease of 46.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 42.65. This value is within the healthy range. It has decreased from 73.42 (Mar 24) to 42.65, marking a decrease of 30.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,277.15. It has decreased from 2,335.08 (Mar 24) to 2,277.15, marking a decrease of 57.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.21 (Mar 24) to 1.16, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 25, the value is 10.70. This value is within the healthy range. It has decreased from 12.23 (Mar 24) to 10.70, marking a decrease of 1.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 1.23 (Mar 24) to 1.18, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 46.31. This value is within the healthy range. It has increased from 42.70 (Mar 24) to 46.31, marking an increase of 3.61.
- For Price / BV (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.54, marking a decrease of 0.33.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 1.23 (Mar 24) to 1.18, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Veedol Corporation Ltd:
- Net Profit Margin: 7.17%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.75% (Industry Average ROCE: 22.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.46% (Industry Average ROE: 17.8%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 42.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.78
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.3 (Industry average Stock P/E: 15.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.17%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Lubricants | 'Yule House', Kolkata West Bengal 700001 | tidecal@veedol.com http://www.veedolindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. D S Chandavarkar | Chairman |
| Mr. Arijit Basu | Managing Director |
| Mr. Vinod S Vyas | Non Exe.Non Ind.Director |
| Mr. Ananta Mohan Singh | Non Exe.Non Ind.Director |
| Mr. P S Bhattacharyya | Ind. Non-Executive Director |
| Mr. Subir Das | Ind. Non-Executive Director |
| Mr. P Y Gurav | Ind. Non-Executive Director |
| Mr. Praveen P Kadle | Ind. Non-Executive Director |
| Mrs. B S Sihag | Ind. Non-Executive Director |
| Dr. Nitin R Gokarn | Ind. Non-Executive Director |
| Mr. Kishore M Saletore | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Veedol Corporation Ltd?
Veedol Corporation Ltd's intrinsic value (as of 10 December 2025) is 1313.68 which is 17.84% lower the current market price of 1,599.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,775 Cr. market cap, FY2025-2026 high/low of 2,035/1,275, reserves of ₹974 Cr, and liabilities of 1,329 Cr.
What is the Market Cap of Veedol Corporation Ltd?
The Market Cap of Veedol Corporation Ltd is 2,775 Cr..
What is the current Stock Price of Veedol Corporation Ltd as on 10 December 2025?
The current stock price of Veedol Corporation Ltd as on 10 December 2025 is 1,599.
What is the High / Low of Veedol Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Veedol Corporation Ltd stocks is 2,035/1,275.
What is the Stock P/E of Veedol Corporation Ltd?
The Stock P/E of Veedol Corporation Ltd is 14.3.
What is the Book Value of Veedol Corporation Ltd?
The Book Value of Veedol Corporation Ltd is 561.
What is the Dividend Yield of Veedol Corporation Ltd?
The Dividend Yield of Veedol Corporation Ltd is 3.38 %.
What is the ROCE of Veedol Corporation Ltd?
The ROCE of Veedol Corporation Ltd is 23.7 %.
What is the ROE of Veedol Corporation Ltd?
The ROE of Veedol Corporation Ltd is 19.8 %.
What is the Face Value of Veedol Corporation Ltd?
The Face Value of Veedol Corporation Ltd is 2.00.